LYEL
Lyell Immunopharma Inc
9.70$
-1.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 3.20 | -13.05 | -10.40 | -13.72 | -13.04 | -12.42 | -8.78 | |
| 0.10 | 0.35 | 1.12 | 1.33 | 1.61 | 1.50 | 0.68 | |
| 1.28 | 2.70 | 5.12 | 6.63 | 3.75 | 2.54 | 2.45 | |
| 4.61 | 3.22 | 8.25 | 6.28 | – | – | – | |
| 8.99 | -0.03 | 0.33 | -6.64 | 0.27 | -0.24 | -0.58 | |
| 1.30 | 4.18 | 5.40 | 1.97 | 0.21 | 0.04 | 0.05 | |
| -34.26 | -22.18 | -10.02 | -0.93 | 14.67 | 9.36 | 3.16 | |
| -0.02 | -0.96 | 33.06 | -0.04 | -0.04 | 2.75 | – | |
| 28.48 | 38.67 | 33.06 | 0.86 | 0.14 | 0.10 | 2.95 | |
| -2.58 | 3.44 | 12.64 | -13.78 | 1.76 | -2.96 | -2.66 | |
| 1.90 | -17.22 | -15.80 | -15.69 | -13.26 | -12.46 | -8.82 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.